December 8–10, 2025 | Indianapolis, IndianaReturning to PRI Show Week – Bigger, Bolder, and More Impactful Than EverPresented by Mobil 1™ for the Fourth...
TSX-V: MSR
TORONTO, July 29, 2025 /CNW/ - Minsud Resources Corp. (TSXV: MSR) ("Minsud" or the "Company"), is pleased to announce the significant results received from its...
SACRAMENTO, Calif., July 29, 2025 /PRNewswire/ -- The California State Educator Workforce Collaborative, a first-ever partnership of 12 education agencies and institutions, today released a...
The triple-negative breast cancer market is expected to grow due to rising incidence rates, increasing awareness, advancements in targeted therapies, ongoing clinical trials, improved...
The triple-negative breast cancer market is expected to grow due to rising incidence rates, increasing awareness, advancements in targeted therapies, ongoing clinical trials, improved...
New Scientific Discovery in Resistant Starch Awakens Metabolic Signals That Vanish After 35 — Helping Over 147,000 Women Reclaim Fat Loss Without Diets, Injections, or Tracking
New Scientific Discovery in Resistant Starch Awakens Metabolic Signals That Vanish After 35 — Helping Over 147,000 Women Reclaim Fat Loss Without Diets, Injections, or Tracking
No alpha-synuclein inhibitors are approved, underscoring a major need for therapies that slow or halt Parkinson's progression. Developing safe, brain-penetrant drugs that target toxic...
LOS ANGELES, July 26, 2025 /PRNewswire/ -- Sling Pilot Academy, one of the nation's fastest-growing flight schools,is now offering qualified aspiring pilots access to...
SANTA ANA, Calif., July 28, 2025 (GLOBE NEWSWIRE) -- NKGen Biotech, Inc. (OTC: NKGN) (“NKGen” or the “Company”), a clinical-stage biotechnology company focused on the development and commercialization of innovative autologous and allogeneic natural killer (“NK”) cell therapeutics, today announced the presentation of a poster entitled, “Mechanism of Action of Troculeucel (Non-genetically Modified Natural Killer Cells with Enhanced Cytotoxicity) in Alzheimer's Disease Confirmed by Corresponding Phase I Biomarker Data” at the Alzheimer’s Association International Conference 2025 (“AAIC 2025”) held in Toronto, Canada and online from July 27-31, 2025.
From finances to business ownership, survey highlights opportunity to close critical information gap and help unlock greater newcomer financial confidence
TORONTO, July 28, 2025 /CNW/...
Students More Than Double State Averages in Proficient and Advanced Performance Levels Across English Language Arts, Math, and Science.
ROGERS, Ark., July 28, 2025 /PRNewswire/...